EUVIMEDEUVIMED entdecken
Crossref

Anisomycin Induces Senescence and Death of Ovarian Cancer Stem Cells Through the MicroRNA‐340/SENP6/SUMOylation Pathway

Lian Yang iD, Ye Xia, Zeyu Cui, Yanchen Lai, Yongyi Huang, Ying Xiong, Juan Chen, Te Liu iD

The Journal of Gene Medicine · 2026

DOI: 10.1002/jgm.70081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Gene Medicine, 2026. Verfasst von Lian Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Geriatric Institute of Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: MicroRNAs, Ovarian Neoplasms, Neoplastic Stem Cells, Anisomycin. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Traditional Chinese Medicine-traditional Chinese patent medicines and clinical evaluation platform.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer remains a leading cause of gynecologic cancer mortality, in part due to the persistence of ovarian cancer stem cells (OCSCs) that drive tumor recurrence, metastasis, and drug resistance. Anisomycin, a natural antibiotic derived from Streptomyces coelicolor , has previously been shown to exert antitumor effects, but the mechanisms by which it targets OCSCs remain unclear. In this study, primary human OCSCs were isolated and treated with anisomycin to investigate its biological and molecular effects. Cell proliferation, apoptosis, migration, and colony formation were assessed in vitro, and tumorigenicity was evaluated in xenograft mouse models. Transcriptomic, biochemical, and molecular assays were performed to identify downstream pathways. Anisomycin treatment markedly inhibited proliferation and promoted senescence and cell death of OCSCs. Mechanistically, anisomycin induced upregulation of microRNA‐340, which in turn suppressed the deSUMOylating enzyme SENP6. This repression increased SUMOylation of key senescence‐related proteins, including p53 and p16, leading to stabilization of their expression and enforcement of cell‐cycle arrest. Overexpression of microRNA‐340 reproduced these effects, both in vitro and in vivo, confirming its central role in mediating anisomycin activity. Bioinformatic analyses further revealed that expression of SENP6 and senescence‐associated genes correlated with disease progression and patient survival in ovarian cancer cohorts. These findings identify a previously unrecognized epigenetic mechanism by which anisomycin induces senescence and death in OCSCs, suggesting that targeting the microRNA‐340/SENP6/SUMOylation pathway may represent a promising therapeutic approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsOvarian NeoplasmsNeoplastic Stem CellsAnisomycinCellular SenescenceSumoylationCysteine EndopeptidasesFemaleHumansAnimalsMiceGene Expression Regulation, NeoplasticCell ProliferationCell Line, TumorApoptosisXenograft Model Antitumor AssaysSignal Transduction

Stichwörter der Autor:innen

anisomycinmicroRNA‐340/SENP6/SUMOylation pathwayovarian cancer stem cellssenescence

Substanzen

MicroRNAsAnisomycinMIRN340 microRNA, humanCysteine Endopeptidases

Autor:innen und Institutionen

  • Shanghai Geriatric Institute of Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Center of Reproductive Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • School of Environmental and Chemical Engineering, Shanghai University, Shanghai, China.
  • Department of Obstetrics and Gynecology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Gongli Hospital Affiliated to the Second Military Medical University in Pudong New Area of Shanghai City, Shanghai, China.

ORCID-Profile: Lian Yang, Te Liu

Förderung

  • Traditional Chinese Medicine-traditional Chinese patent medicines and clinical evaluation platform

Zitieren

APA

Yang, L., Xia, Y., Cui, Z., Lai, Y., Huang, Y., Xiong, Y., Chen, J., & Liu, T. (2026). Anisomycin Induces Senescence and Death of Ovarian Cancer Stem Cells Through the MicroRNA‐340/SENP6/SUMOylation Pathway. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.70081

Vancouver

Yang L, Xia Y, Cui Z, Lai Y, Huang Y, Xiong Y, et al. Anisomycin Induces Senescence and Death of Ovarian Cancer Stem Cells Through the MicroRNA‐340/SENP6/SUMOylation Pathway. The Journal of Gene Medicine. 2026. doi:10.1002/jgm.70081

BibTeX
@article{Yang2026,
  author = {Yang, Lian and Xia, Ye and Cui, Zeyu and Lai, Yanchen and Huang, Yongyi and Xiong, Ying and Chen, Juan and Liu, Te},
  title = {Anisomycin Induces Senescence and Death of Ovarian Cancer Stem Cells Through the MicroRNA‐340/SENP6/SUMOylation Pathway},
  journal = {The Journal of Gene Medicine},
  year = {2026},
  doi = {10.1002/jgm.70081}
}
Kostenlos starten →